CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is 0.18 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $140,200,000 | +0.8% | 1,184,021 | +0.5% | 1.34% | -20.4% |
| Q4 2020 | $139,134,000 | +169.7% | 1,178,000 | +153.8% | 1.68% | +152.0% |
| Q3 2020 | $51,583,000 | +26.3% | 464,128 | +16.2% | 0.67% | -8.3% |
| Q2 2020 | $40,828,000 | +132.4% | 399,570 | +145.5% | 0.73% | +150.7% |
| Q1 2020 | $17,568,000 | +39.6% | 162,772 | +50.5% | 0.29% | +40.8% |
| Q4 2019 | $12,586,000 | +31.7% | 108,149 | +29.5% | 0.21% | +38.3% |
| Q3 2019 | $9,557,000 | – | 83,490 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |